Revvity, Inc. (NYSE:RVTY) Stock Holdings Lifted by Martin Currie Ltd.

Martin Currie Ltd. increased its position in shares of Revvity, Inc. (NYSE:RVTY) by 52.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,286 shares of the company’s stock after acquiring an additional 3,902 shares during the quarter. Martin Currie Ltd.’s holdings in Revvity were worth $1,260,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of Revvity in the fourth quarter valued at $127,801,000. EdgePoint Investment Group Inc. lifted its position in shares of Revvity by 34.6% in the third quarter. EdgePoint Investment Group Inc. now owns 2,685,775 shares of the company’s stock worth $343,108,000 after purchasing an additional 690,534 shares in the last quarter. Southpoint Capital Advisors LP acquired a new stake in shares of Revvity during the third quarter worth approximately $25,550,000. Proficio Capital Partners LLC grew its position in Revvity by 12,298.3% during the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company’s stock valued at $21,850,000 after purchasing an additional 194,190 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Revvity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company’s stock valued at $1,594,930,000 after purchasing an additional 156,679 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Trading Down 1.6 %

Shares of RVTY stock opened at $105.65 on Friday. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50. The company has a market cap of $12.69 billion, a PE ratio of 47.81, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The business’s 50 day moving average is $115.16 and its two-hundred day moving average is $117.16.

Revvity (NYSE:RVTY) last announced its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the firm posted $1.25 EPS. Equities analysts predict that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.27%. Revvity’s dividend payout ratio is presently 12.67%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on RVTY shares. KeyCorp increased their target price on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Barclays lifted their price objective on Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price on the stock in a research report on Friday, December 13th. Raymond James reiterated an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a report on Monday, February 3rd. Finally, Sanford C. Bernstein downgraded Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective on the stock. in a report on Friday, January 10th. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Revvity presently has a consensus rating of “Moderate Buy” and an average price target of $136.25.

Insider Activity at Revvity

In other news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the sale, the insider now owns 19,652 shares of the company’s stock, valued at approximately $2,295,550.12. The trade was a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.68% of the stock is owned by corporate insiders.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.